Latest SEC Filings

CODEXIS, INC.Codexis Reports Q2 2026 Financial Results with Revenue of $14.9 Million

Mobile Infrastructure CorpMobile Infrastructure Corporation Reports Q2 2026 Financial Results with Revenue Decline

Global Arena Holding, Inc.Global Arena Holding Reports $1.27 Million Net Loss and $1.93 Million Revenue for Fiscal Year 2025

Inhibikase Therapeutics, Inc.Inhibikase Therapeutics Reports $19.6 Million Net Loss and Increased R&D Expenses in Latest Quarter

WATERS CORP /DE/Waters Corporation Reports 113% Revenue Growth but $136 Million Net Loss in Latest Quarter

Stran & Company, Inc.Stran & Company Reports 2.4% Sales Increase in Q2 2026

TANDY LEATHER FACTORY INCTandy Leather Factory Reports Q2 2026 Financial Results with Increased Sales and Return to Profitability

INTELLIGENT PROTECTION MANAGEMENT CORP.Intelligent Protection Management Corp. Reports 13% Revenue Growth to $6.5 Million in Q2 2026

Highview Merger Corp.Highview Merger Corp. Reports $1.89 Million Net Income in Q2 2026

Bluerock Acquisition Corp.Bluerock Acquisition Corp. Reports Q2 2026 Financial Results and Business Combination Agreement with Bitonic Technology Labs Inc.

Proem Acquisition Corp. IProem Acquisition Corp I Reports Financial Results for Quarter Ending June 30, 2026

CalciMedica, Inc.CalciMedica Reports $7.7 Million Net Loss in Q2 2026, Sees Improvement in Financial Position

Modiv Industrial, Inc.Modiv Industrial Reports Q2 2026 Financial Recovery with $6.5M Net Income

AramarkAramark Reports 9.3% Revenue Growth to $5.06 Billion in Q3 Fiscal 2026

Jackson Acquisition Co IIJackson Acquisition Company II Reports Decrease in Net Income and Increased Liabilities for Q2 2026

Cartesian Growth Corp IIIFactorial Energy Inc. Reports Q2 2026 Financial Results with Increased Cash Reserves and Net Loss

Autolus Therapeutics plcAutolus Therapeutics Reports 118% Revenue Growth to $45.7 Million in Q2 2026

Global Arena Holding, Inc.Global Arena Holding Reports 120% Revenue Growth but Increased Net Loss in Latest Quarter

LENZ Therapeutics, Inc.LENZ Therapeutics Reports Q2 2026 Financial Results with $5.5M Revenue and $31.9M Net Loss

Fold Holdings, Inc.Fold Holdings Reports 26% Revenue Decline in Q2 2026 Amid Market Downturn

EBR Systems, Inc.EBR Systems Reports $2.6M in Q2 Revenue, Faces $17.5M Net Loss

BridgeBio Oncology Therapeutics, Inc.BridgeBio Oncology Reports $56.5M Net Loss in Q2 2026, Increases R&D Expenses

INTERFACE INCInterface, Inc. Reports 5.4% Revenue Growth to $395.7 Million in Q2 Fiscal 2026

Neutron Holdings, Inc.Neutron Holdings Reports 24% Revenue Growth and Significant Net Income Increase in Latest Quarter

Global Arena Holding, Inc.Global Arena Holding Reports 30% Revenue Increase but Continues to Face Operational Losses in Q3 2025